Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07244640

Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease

Clinical Study on Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Accepted

Summary

The objective of this observational study is to investigate whether non-invasive fundus retinal detection technology can be used for the early diagnosis of parkinson's disease (PD). It aims to answer the following primary questions: the sensitivity and specificity of non-invasive fundus retinal detection technology in the early diagnosis of PD; and whether this technology offers advantages over dopamine transporter positron emission tomography (DAT-PET), a conventional screening method for PD. The researchers will analyze the diagnostic performance of this technology for early-stage PD patients among cohorts including early parkinson's disease, parkinson's syndromes, essential tremor patients, and healthy individuals. Furthermore, in PD patients who concurrently undergo DAT-PET imaging, the study will compare the diagnostic value of non-invasive retinal imaging against that of DAT-PET.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTnon-invasive fundus retinal detectionfunctional optical coherence tomography angiography-retinal neurovascular coupling (fOCTA-rNVC) detection technology

Timeline

Start date
2025-11-01
Primary completion
2028-12-01
Completion
2028-12-01
First posted
2025-11-24
Last updated
2025-11-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07244640. Inclusion in this directory is not an endorsement.